(HealthDay)—There is a high prevalence of financial conflicts of interest among authors of clinical practice guidelines (CPGs) related to high-revenue medications and in gastroenterology, according to two research letters ...
Nov 1, 2018
0
0
Physician payment models are becoming more complex and the pace of change is increasing, creating challenges for physician practices that might hamper their ability to improve the quality and efficiency of care despite their ...
Oct 24, 2018
0
0
Since 2013, gifts and payments to doctors by pharmaceutical and medical device companies have been publicly reported. In addition, some medical centers, physician employers, such as Kaiser Permanente, and states have banned ...
Oct 19, 2018
0
3
In a new report, researchers at the University of York have investigated the ways in which the value of new antimicrobial drugs could be assessed to help the NHS decide how much should be paid for them.
Oct 8, 2018
0
0
A substantial proportion of pharmaceutical industry payments to authors of oncology clinical trials published in major scientific journals are not disclosed, new research shows. The publications focused on clinical trials ...
Aug 30, 2018
0
3
(HealthDay)—Bundling of payments for five common medical conditions is not associated with changes in Medicare payments per episode or health outcomes, according to a study published in the July 19 issue of the New England ...
Aug 13, 2018
0
0
(HealthDay)—In a letter sent to Administrator Seema Verma of the Centers for Medicare & Medicaid Services (CMS), medical organizations are urging reconsideration of the decision to suspend payments to insurers as required ...
Aug 4, 2018
0
1
(HealthDay)—Cumulative reductions in federal payments to hospitals from 2010 to 2028 are estimated to reach $218.2 billion, according to a study commissioned by the Federation of American Hospitals and the American Hospital ...
Jul 6, 2018
0
2
Members of Innovative Medicines Canada (IMC), the lobby group for the large pharmaceutical companies, recently released their voluntary reports of payments to health-care professionals and health-care organizations.
Jul 5, 2018
0
46
Medicare recipients filled fewer prescriptions for pricey brand-name drugs—but spent more on such meds anyway, says a government report due out Monday. It blames rising manufacturer prices for squeezing older people and ...
Jun 4, 2018
0
4
